Skip to main content
Top
Published in: Journal of Experimental & Clinical Cancer Research 1/2009

Open Access 01-12-2009 | Research

In vivo99mTc-HYNIC-annexin V imaging of early tumor apoptosis in mice after single dose irradiation

Authors: Ming-fang Guo, Yaqing Zhao, Rong Tian, Lin Li, Leiming Guo, Feng Xu, Yong-mei Liu, Yong-bo He, Sen Bai, Jin Wang

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2009

Login to get access

Abstract

Background

Apoptosis is a major mode of hematological tumor death after radiation. Early detection of apoptosis may be beneficial for cancer adaptive treatment. 99mTc-HYNIC-annexinV has been reported as a promising agent for in vivo apoptosis imaging. The purpose of this study is to evaluate the feasibility of in vivo99mTc-HYNIC-annexinV imaging of radiation- induced apoptosis, and to investigate its correlation with radiosensitivity.

Methods

Ten days after inoculation of tumor cells in the right upper limbs, the mice were randomly divided into two groups. The imaging group (4 mice each level, 4 dose levels) was injected with 4-8 MBq 99mTc-HYNIC-annexinV 24 hours after irradiation and imaged 1 hr post-injection, and the mice were sacrificed immediately after imaging for biodistribution analysis of annexin V. The observation group (4 mice each level, 2 dose levels) was only observed for tumor regression post-radiation. The number of apoptotic cells in a tumor was estimated with TUNEL assay.

Results

The 99mTc-HYNIC-annexin V uptake in E14 lymphoma significantly increased as the radiation dose escalated from 0 to 8 Gy, and significantly correlated with the number of TUNEL-positive cells (r = 0.892, P < 0.001). The Annexin-V uptake and the number of TUNEL-positive cells in El4 lymphoma were significantly greater than those in S180 sarcoma. With 8 Gy, S180 sarcoma tumor showed scanty apoptosis and less shrinkage while El4 lymphoma showed remarkable apoptosis and complete remission.

Conclusion

99mTc-HYNIC-annexinV in vivo imaging is a feasible method to detect early radiation-induced apoptosis in different tumors, and might be predictive for radiation sensitivity.
Appendix
Available only for authorised users
Literature
1.
go back to reference Shinomiya N: New concepts in radiation-induced apoptosis:'premitotic apoptosis' and 'postmitotic apoptosis'. J Cell Mol Med. 2001, 5: 240-253. 10.1111/j.1582-4934.2001.tb00158.x.CrossRef Shinomiya N: New concepts in radiation-induced apoptosis:'premitotic apoptosis' and 'postmitotic apoptosis'. J Cell Mol Med. 2001, 5: 240-253. 10.1111/j.1582-4934.2001.tb00158.x.CrossRef
2.
go back to reference Pervan M, Pajonk F, Sun JR, Withers HR, McBride WH: Molecular pathways that modify tumor radiation response. Am J Clin Oncol. 2001, 24: 481-485. 10.1097/00000421-200110000-00013.CrossRef Pervan M, Pajonk F, Sun JR, Withers HR, McBride WH: Molecular pathways that modify tumor radiation response. Am J Clin Oncol. 2001, 24: 481-485. 10.1097/00000421-200110000-00013.CrossRef
3.
go back to reference Narula J, Straus HW: Implications of Phosphatidylserine (PS) reversal in acute ischemic syndromes. J Nucl Med. 2003, 44: 397-399. Narula J, Straus HW: Implications of Phosphatidylserine (PS) reversal in acute ischemic syndromes. J Nucl Med. 2003, 44: 397-399.
4.
go back to reference Zhu L, Liu M, Shen R, He ZX: Application of Annexin V in nuclear medicine apoptosis imaging [Article in Chinese]. Chin J Nucl Med. 2004, 24: 379-381. Zhu L, Liu M, Shen R, He ZX: Application of Annexin V in nuclear medicine apoptosis imaging [Article in Chinese]. Chin J Nucl Med. 2004, 24: 379-381.
5.
go back to reference Blankenberg FG, Katsikis PD, Tait JF, R Davis E, Naumovski L, Ohtsuki K, Kopiwoda S, Abrams MJ, Darkes M, Robbins RC, Maecker HT, Strauss HW: In vivo detection and imaging of phosphatidylserine expression during programmed cell death. PNAS. 1998, 95: 6349-6354. 10.1073/pnas.95.11.6349.CrossRef Blankenberg FG, Katsikis PD, Tait JF, R Davis E, Naumovski L, Ohtsuki K, Kopiwoda S, Abrams MJ, Darkes M, Robbins RC, Maecker HT, Strauss HW: In vivo detection and imaging of phosphatidylserine expression during programmed cell death. PNAS. 1998, 95: 6349-6354. 10.1073/pnas.95.11.6349.CrossRef
6.
go back to reference Wang RF, Liu M, Zhang CL, Guo FQ, Zhao GY: Experimental study on tumor cell apoptosis imaging in vivo with 99m Tc-HYNIC-Annexin V in tumor-bearing mice. Chin J Med Imaging Technol. 2005, 11: 1663-1666. Wang RF, Liu M, Zhang CL, Guo FQ, Zhao GY: Experimental study on tumor cell apoptosis imaging in vivo with 99m Tc-HYNIC-Annexin V in tumor-bearing mice. Chin J Med Imaging Technol. 2005, 11: 1663-1666.
7.
go back to reference Kartachova M, Haasb RL, Olmosa RA, Hoebersb FJ, Zandwijkc Nv, Verheijb M: In vivo imaging of apoptosis by 99mTc-Annexin V scintigraphy:visual analysis in relation to treatment response. Radiother Oncol. 2004, 72: 333-339. 10.1016/j.radonc.2004.07.008.CrossRef Kartachova M, Haasb RL, Olmosa RA, Hoebersb FJ, Zandwijkc Nv, Verheijb M: In vivo imaging of apoptosis by 99mTc-Annexin V scintigraphy:visual analysis in relation to treatment response. Radiother Oncol. 2004, 72: 333-339. 10.1016/j.radonc.2004.07.008.CrossRef
8.
go back to reference Haas RL, Jong D, Olmos RA, Hoefnagel CA, Heuvel ID, Zerp SF, Bartelink H, Verheij M: In vivo imaging of radiation-induced apoptosis in follicular lymphoma patients. Int J Radiat Oncol Biol Phys. 2004, 59: 782-787.CrossRef Haas RL, Jong D, Olmos RA, Hoefnagel CA, Heuvel ID, Zerp SF, Bartelink H, Verheij M: In vivo imaging of radiation-induced apoptosis in follicular lymphoma patients. Int J Radiat Oncol Biol Phys. 2004, 59: 782-787.CrossRef
9.
go back to reference Larsen SK, Solomon HF, Caldwell G, Abrams MJ: [99mTc] tricine: a useful precursor complex for the radiolabeling of hydrazinonicotinate protein conjugates. Bioconju Chem. 1995, 6: 635-638. 10.1021/bc00035a020.CrossRef Larsen SK, Solomon HF, Caldwell G, Abrams MJ: [99mTc] tricine: a useful precursor complex for the radiolabeling of hydrazinonicotinate protein conjugates. Bioconju Chem. 1995, 6: 635-638. 10.1021/bc00035a020.CrossRef
10.
go back to reference Verbeke K, Kieffer D, Vanderheyden JL, Reutelingsperger C, Steinmetz ND, Green AM, Verbruggen A: Optimization of the preparation of (99m)Tc-labeled Hynic-derivatized Annexin V for human use. Nucl Med Biol. 2003, 30: 771-778. 10.1016/S0969-8051(03)00056-8.CrossRef Verbeke K, Kieffer D, Vanderheyden JL, Reutelingsperger C, Steinmetz ND, Green AM, Verbruggen A: Optimization of the preparation of (99m)Tc-labeled Hynic-derivatized Annexin V for human use. Nucl Med Biol. 2003, 30: 771-778. 10.1016/S0969-8051(03)00056-8.CrossRef
11.
go back to reference Mochizuki T, Kuge Y, Zhao Sj, Tsukamoto E, Hosokawa M, Strauss HW, Blankenberg FG, Tait JF, Tamaki N: Detection of apoptotic tumor response in vivo after a single dose of chemotherapy with 99mTc-Annexin V. J Nucl Med. 2003, 44: 92-97. Mochizuki T, Kuge Y, Zhao Sj, Tsukamoto E, Hosokawa M, Strauss HW, Blankenberg FG, Tait JF, Tamaki N: Detection of apoptotic tumor response in vivo after a single dose of chemotherapy with 99mTc-Annexin V. J Nucl Med. 2003, 44: 92-97.
12.
go back to reference Wong E, Kumar V, Howman-Giles RB, Vanderheyden JL: Imaging of Therapy-Induced Apoptosis Using 99mTc-HYNIC-Annexin V in Thymoma Tumor-Bearing Mice. Cancer Biother Radiopharm. 2008, 23: 715-725. 10.1089/cbr.2008.0504.CrossRef Wong E, Kumar V, Howman-Giles RB, Vanderheyden JL: Imaging of Therapy-Induced Apoptosis Using 99mTc-HYNIC-Annexin V in Thymoma Tumor-Bearing Mice. Cancer Biother Radiopharm. 2008, 23: 715-725. 10.1089/cbr.2008.0504.CrossRef
13.
go back to reference Hammill AK, Uhr JW, Scheuermann RH: Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic death. Exp Cell Res. 1999, 251: 16-21. 10.1006/excr.1999.4581.CrossRef Hammill AK, Uhr JW, Scheuermann RH: Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic death. Exp Cell Res. 1999, 251: 16-21. 10.1006/excr.1999.4581.CrossRef
14.
go back to reference Martin S, Pombo I, Poncet P, David B, Arock M, Blank U: Immunologic stimulation of mast cells leads to the reversible exposure of phosphatidylserine in the absence of apoptosis. Int Arch Allergy Immunol. 2000, 123: 249-258. 10.1159/000024451.CrossRef Martin S, Pombo I, Poncet P, David B, Arock M, Blank U: Immunologic stimulation of mast cells leads to the reversible exposure of phosphatidylserine in the absence of apoptosis. Int Arch Allergy Immunol. 2000, 123: 249-258. 10.1159/000024451.CrossRef
15.
go back to reference Geske FJ, Monks J, Lehman L, Fadok VA: The role of the macrophage in apoptosis: hunter, gatherer, and regulator. Int J Hematol. 2002, 76: 16-26. 10.1007/BF02982714.CrossRef Geske FJ, Monks J, Lehman L, Fadok VA: The role of the macrophage in apoptosis: hunter, gatherer, and regulator. Int J Hematol. 2002, 76: 16-26. 10.1007/BF02982714.CrossRef
16.
go back to reference Yang DJ, Azhdarinia A, Wu P, Yu DF, Tansey W, Kalimi SK, Kim EE, Podoloff DA: In vivo and in vitro measurement of apoptosis in breast cancer cells using 99mTc-EC-annexin V. Cancer Biother Radiopharm. 2001, 16: 73-83. 10.1089/108497801750096087.CrossRef Yang DJ, Azhdarinia A, Wu P, Yu DF, Tansey W, Kalimi SK, Kim EE, Podoloff DA: In vivo and in vitro measurement of apoptosis in breast cancer cells using 99mTc-EC-annexin V. Cancer Biother Radiopharm. 2001, 16: 73-83. 10.1089/108497801750096087.CrossRef
17.
go back to reference Liu ZZ, Huang WY, Li XS, Lin JS, Cai XK, Lian KH, Zhou HJ: Prediction value of radiosensitivity of hepatocarcinoma cells for apoptosis and micronucleus assay. World J Gastroenterol. 2005, 11: 7036-7039.CrossRef Liu ZZ, Huang WY, Li XS, Lin JS, Cai XK, Lian KH, Zhou HJ: Prediction value of radiosensitivity of hepatocarcinoma cells for apoptosis and micronucleus assay. World J Gastroenterol. 2005, 11: 7036-7039.CrossRef
18.
go back to reference Sheridan MT, West CM: Ability to undergo apoptosis dose not correlate with the intrinsic radiosensitivity (SF2) of human cervix tumor cell lines. Int J Radiat Oncol Biol Phys. 2001, 50: 503-509. 10.1016/S0360-3016(01)01496-1.CrossRef Sheridan MT, West CM: Ability to undergo apoptosis dose not correlate with the intrinsic radiosensitivity (SF2) of human cervix tumor cell lines. Int J Radiat Oncol Biol Phys. 2001, 50: 503-509. 10.1016/S0360-3016(01)01496-1.CrossRef
19.
go back to reference Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A, Fuks Z, Kolesnick R: Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science. 2003, 300: 1155-1159. 10.1126/science.1082504.CrossRef Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A, Fuks Z, Kolesnick R: Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science. 2003, 300: 1155-1159. 10.1126/science.1082504.CrossRef
20.
go back to reference Brown JM, Koong A: High-dose single-fraction radiotherapy: exploitation a new biology?. Int J Radiat Oncol Biol Phys. 2008, 71: 324-325.CrossRef Brown JM, Koong A: High-dose single-fraction radiotherapy: exploitation a new biology?. Int J Radiat Oncol Biol Phys. 2008, 71: 324-325.CrossRef
21.
go back to reference Hong M, Lai MD, Lin YS, Lai MZ: Antagonism of p53-dependent Apoptosis by Mitogen Signals. Cancer Res. 1999, 59: 2847-2852. Hong M, Lai MD, Lin YS, Lai MZ: Antagonism of p53-dependent Apoptosis by Mitogen Signals. Cancer Res. 1999, 59: 2847-2852.
22.
go back to reference Dubray B, Breton C, Delic J, Klijanienko J, Maciorowski Z, Vielh P, Fourquet A, Dumont J, Magdelenat H, Cosset JM: In vitro radiation-induced apoptosis and early response to low-dose radiotherapy in non-Hodgkin's lymphomas. Radiother Oncol. 1998, 46: 185-191. 10.1016/S0167-8140(97)00148-5.CrossRef Dubray B, Breton C, Delic J, Klijanienko J, Maciorowski Z, Vielh P, Fourquet A, Dumont J, Magdelenat H, Cosset JM: In vitro radiation-induced apoptosis and early response to low-dose radiotherapy in non-Hodgkin's lymphomas. Radiother Oncol. 1998, 46: 185-191. 10.1016/S0167-8140(97)00148-5.CrossRef
23.
go back to reference Rottey S, Loose D, Vakaet L, Lahorte C, Vermeersch H, Van Belle S, Wiele Van de C: 99mTc-HYNIC Annexin-V imaging of tumors and its relationship to response to radiotherapy and/or chemotherapy. Quart J Nucl Med Mol Imag. 2007, 51: 182-188. Rottey S, Loose D, Vakaet L, Lahorte C, Vermeersch H, Van Belle S, Wiele Van de C: 99mTc-HYNIC Annexin-V imaging of tumors and its relationship to response to radiotherapy and/or chemotherapy. Quart J Nucl Med Mol Imag. 2007, 51: 182-188.
24.
go back to reference Hoebers FJ, Kartachova M, de Bois J, Brekel van den M, van Tinteren H, van Herk M, Rasch CRN, Valdés ORA, Verheij M: 99mTc Hynic-rh-Annexin V scintigraphy for in vivo imaging of apoptosis in patients with head and neck cancer treated with chemoradiotherapy. Eur J Nucl Med Mol Imaging. 2008, 35: 509-518. 10.1007/s00259-007-0624-x.CrossRef Hoebers FJ, Kartachova M, de Bois J, Brekel van den M, van Tinteren H, van Herk M, Rasch CRN, Valdés ORA, Verheij M: 99mTc Hynic-rh-Annexin V scintigraphy for in vivo imaging of apoptosis in patients with head and neck cancer treated with chemoradiotherapy. Eur J Nucl Med Mol Imaging. 2008, 35: 509-518. 10.1007/s00259-007-0624-x.CrossRef
Metadata
Title
In vivo99mTc-HYNIC-annexin V imaging of early tumor apoptosis in mice after single dose irradiation
Authors
Ming-fang Guo
Yaqing Zhao
Rong Tian
Lin Li
Leiming Guo
Feng Xu
Yong-mei Liu
Yong-bo He
Sen Bai
Jin Wang
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Journal of Experimental & Clinical Cancer Research / Issue 1/2009
Electronic ISSN: 1756-9966
DOI
https://doi.org/10.1186/1756-9966-28-136

Other articles of this Issue 1/2009

Journal of Experimental & Clinical Cancer Research 1/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine